Cargando…
Fulminant Liver Failure after Treatment with a Checkpoint Inhibitor for Gastric Cancer: A Case Report and Review of the Literature
Nivolumab is a promising monoclonal antibody inhibitor of programmed death-1, a protein on the surface of T-cells. As such, it is approved for use in patients with multiple advanced malignancies and can significantly elongate progression-free survival. However, monoclonal antibody inhibitors can lea...
Autores principales: | Dibos, Miriam, Dumoulin, Johanna, Mogler, Carolin, Wunderlich, Silke, Reichert, Maximilian, Rasch, Sebastian, Schmid, Roland M., Ringelhan, Marc, Ehmer, Ursula, Lahmer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381004/ https://www.ncbi.nlm.nih.gov/pubmed/37510756 http://dx.doi.org/10.3390/jcm12144641 |
Ejemplares similares
-
Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients
por: Kager, Juliane, et al.
Publicado: (2022) -
(Seltene) infektiöse Hepatitiden als wichtige Differenzialdiagnose der unklaren Hepatopathie
por: Wührl, Michael, et al.
Publicado: (2022) -
Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study
por: Rothe, Kathrin, et al.
Publicado: (2023) -
Influence of a Structured Microbiological Endotracheal Monitoring Program on the Outcome of Critically Ill COVID-19 Patients: An Observational Study
por: Dibos, Miriam, et al.
Publicado: (2023) -
Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature
por: Bauer, Ulrike, et al.
Publicado: (2022)